Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk has invested 6.4 billion Brazilian reais ($1.09 billion, €0.99 billion) to expand its facility in Brazil as the company ramps up efforts to increase production of its flagship glucagon-like peptide 1 receptor agonist (GLP-1RA) products. Novo …